Gary J. Nabel
Chief Innovation Officer & DirectorDr. Gary J. Nabel, M. D., Ph. D. He serves as Chief Innovation Officer at OPKO Health, Inc. since April 2026. He has been Independent Director of SIGA Technologies, Inc. since June 15, 2021. He serves as Independent Director of Candel Therapeutics, Inc. since August 08, 2022 and also serves as its Member of Research Advisory Board. He served as the Chief Scientific Officer at Sanofi since November 2012 and its Senior Vice President since December 2012. He serves as Chief Executive Officer of ModeX Therapeutics and he served as President and Chief Executive Officer of ModeX Therapeutics from November 2020 until May 2022. Dr. Nabel serves as Director at OPKO Health, Inc. since May 09, 2022 and served as its Chief Information Officer since 2025 until April 2026 and served as its Chief Innovation Officer since May 09, 2022 until 2025. Dr. Nabel also served as Deputy to the President for Global Research & Development at Sanofi since November 2012. He served as Head of the North American Research & Development Hub at Sanofi. In addition to serving as Senior Vice President for the company, Dr. Nabel also oversaw the Breakthrough Lab, which developed the first trispecific antibodies now in development for HIV as published in Science, as well as cancer immunotherapies and novel vaccines. Dr. Nabel served as Chairman and Member of Scientific Advisory Board at VBI Vaccines Inc. He served as the Chairman and Member of the Strategic Development and Scientific Advisory Council at Sanofi since January 2013. He serves as a Director of NIH Vaccine Institute. He was Director of the Vaccine Research Center from 1999 to November 2012. He was a postdoctoral fellow in the laboratory of David Baltimore at the WhiteHead Institute at the Massachusetts Institute of Technology (MIT). Among his many other honors, Dr. Nabel received the Amgen Scientific Achievement Award from the American Society for Biochemistry and Molecular Biology, the Health and Human Services Secretary's Award for Distinguished Service and is a fellow of the American Association of Physicians and the American Academy of Arts Sciences. He was a Member of the Institute of Medicine of the National Academy of Sciences in 1998. Dr. Nabel graduated magna cum laude from Harvard College in 1975 and continued his graduate studies at Harvard, completing his Ph. D. in 1980 and his M. D. years later, followed by a post-doctoral fellowship with David Baltimore at the WhiteHead Institute.
Positions
- Company NameOPKO Health, Inc.Stock CodeOPKPositionChief Innovation Officer & DirectorColleagues
